DREAMS-OT Trial: Delirium Reduction Through Early Activation in Motivating and Sleep Promoting Routines: A Randomized Controlled Trial of Occupational Therapy for ICU Patients After Coronary Artery Bypass Graft (CABG) Surgery

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Oct 24, 2023

Keywords

ClinConnect Summary

The DREAMS-OT Trial aims to find out if a special type of occupational therapy can help reduce delirium in patients who have just had heart surgery called Coronary Artery Bypass Graft (CABG). Delirium is a sudden change in mental function that can happen after surgery, and the goal of this study is to see if the DREAMS-OT approach is more effective than standard care in preventing this condition in patients recovering in the intensive care unit (ICU). The study will compare two groups of patients: one group will receive the new therapy, while the other will receive the usual care. Researchers will look at how many patients experience delirium five days after their surgery.

To be eligible for this trial, participants must be at least 21 years old, be able to speak either English or Mandarin, and be medically cleared for elective CABG surgery. Unfortunately, patients who cannot provide consent, have severe hearing or cognitive impairments, or are experiencing serious complications will not be able to participate. The trial is not currently recruiting participants, but it is an important step in understanding how we can better support recovery after heart surgery and improve patients' mental health during their hospital stay.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients deemed medically suitable for elective CABG surgery
• • Patients aged 21 years and above
• • Patients who are English or Mandarin speaking.
• • Patients who are able to provide consent
• Exclusion Criteria:
• • Patients who speak other languages are excluded due to the language requirements of certain outcome measures.
• • Patients with premorbid severe hearing impairment, severe cognitive impairment, progressive neurological disorders and psychological disorders will be excluded.
• • Patients with surgical complications resulting in profuse bleeding from any invasive sites, septic shock unresponsive to maximal treatment, and those who are moribund or have an expected mortality within 48 hours will be excluded.
• • Pregnant women will also be excluded from the study as well.
• • Patients who develop delirium before initiation of the treatment are also excluded from the study.